Evidence map›Paper›PMID 26789234›Full record

ArticlePharmaceutical biology2016

Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes.

Keanu D Pinner, Christina T K Wales, Rachel A Gristock, Hoa T Vo, Nadine So, Aaron T Jacobs

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Pharmaceutical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Protective effect of kava constituents in an in vitro model of oral mucositis.Journal of cancer research and clinical oncology · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Keanu D Pinnera Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;
Christina T K Walesa Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;
Rachel A Gristocka Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;
Hoa T Voa Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;
Nadine Soa Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;
Aaron T Jacobsa Department of Pharmaceutical Sciences , Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo , Hilo , HI , USA ;
University of Hawaii at Hilo · USUniversity of Hawaii System · US

Funding

UH Hilo COP A&RP20GM103466 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI Peter R Hoffmann · 2012 to 2026
$60.3M
NIGMS NIH HHS P20 GM103466
6 · The paper itself

Abstract

Context Flavokawains are secondary metabolites from the kava plant (Piper methysticum Forst. f., Piperaceae) that have anticancer properties and demonstrated oral efficacy in murine cancer models. However, flavokawains also have suspected roles in rare cases of kava-induced hepatotoxicity. Objective To compare the toxicity flavokawains A and B (FKA, FKB) and monitor the resulting transcriptional responses and cellular adaptation in the human hepatocyte cell line, HepG2. Materials and methods HepG2 were treated with 2-100 μM FKA or FKB for 24-48 h. Cellular viability was measured with calcein-AM and changes in signalling and gene expression were monitored by luciferase reporter assay, real-time PCR and Western blot of both total and nuclear protein extracts. To test for subsequent resistance to oxidative stress, cells were pretreated with 50 μM FKA, 10 μM FKB or 10 μM sulphoraphane (SFN) for 24 h, followed by 0.4-2.8 mM H2O2 for 48 h, and then viability was assessed. Results FKA (≤100 μM) was not toxic to HepG2, whereas FKB caused significant cell death (IC50=23.2 ± 0.8 μM). Both flavokawains activated Nrf2, increasing HMOX1 and GCLC expression and enhancing total glutathione levels over 2-fold (p < 0.05). FKA and FKB also activated HSF1, increasing HSPA1A and DNAJA4 expression. Also, flavokawain pretreatment mitigated cell death after a subsequent challenge with H2O2, with FKA being more effective than FKB, and similar to SFN. Conclusions Flavokawains promote an adaptive cellular response that protects hepatocytes against oxidative stress. We propose that FKA has potential as a chemopreventative or chemotherapeutic agent.

Indexed as

KavaAntioxidantsCell SurvivalChalconeCytoprotectionDose-Response Relationship, DrugFlavonoidsGlutamate-Cysteine LigaseGlutathioneHeat-Shock ResponseHeme Oxygenase-1HepatocytesHep G2 CellsHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansAntioxidantsChalconeDNAJA4 protein, humanflavokawain Aflavokawain BFlavonoidsGCLC protein, humanGlutamate-Cysteine LigaseGlutathioneHeme Oxygenase-1HMOX1 protein, humanHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHSPA1A protein, humanHydrogen PeroxideNFE2L2 protein, humanNF-E2-Related Factor 2Plant ExtractsCell stresshepatotoxicHSF1Nrf2viability

Identifiers

PMID26789234
PMCPMC5040346
OpenAlexW2266077892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.